Glucagon-like peptide-1 (GLP-1) acts through its G-protein-coupled receptor to enhance
glucose-stimulated insulin secretion from pancreatic β-cells. This is believed to result from …

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects
women of reproductive age. Metabolic consequences associated with PCOS include, but …

The proglucagon gene gives rise to multiple peptides that play diverse roles in the control of
energy intake, gut motility, and nutrient disposal. Glucagon-like peptide-1 (GLP-1), a 30 …

This study comprised 2 experiments that tested the hypothesis that a high-amylose starch
diet (AMO) would improve body weight and glycemic control relative to a high-amylopectin …

There is compelling evidence implicating intestinal permeability in the pathogenesis of
nonalcoholic steatohepatitis (NASH), but the underlying mechanisms remain poorly …

Glucagon-like peptide-2 (GLP-2) regulates energy homeostasis via effects on nutrient
absorption and maintenance of gut mucosal epithelial integrity. The biological actions of …

Abstract Glucagon-like peptide-1 (7–36)-amide (GLP-1) is an endogenous peptide that is
secreted from the gut in response to the presence of food. Recent studies have established …

Antagonism of voltage-dependent K+(Kv) currents in pancreatic β-cells may contribute to the
ability of glucagon-like peptide-1 (GLP-1) to stimulate insulin secretion. The mechanism and …

Type 2 diabetes is a chronic disease characterized by progressive worsening of glycaemic
control as indicated by the United Kingdom Prospective Diabetes Study (UKPDS). The …

This systematic review aimed at addressing the ursolic acid actions as an adjunctive
treatment of the obesity‐mediated metabolic abnormalities. To explore our aims, we used …